New pressure-to-cornea index in glaucoma created

Article

A new pressure-to-cornea index (PCI) has been created in an attempt to integrate intraocular pressure (IOP) and central corneal thickness (CCT) into a unified risk factor.

A new pressure-to-cornea index (PCI) has been created in an attempt to integrate intraocular pressure (IOP) and central corneal thickness (CCT) into a unified risk factor, according to a report published in the October issue of the British Journal of Ophthalmology.

Milko Iliev from the University of Bern, Switzerland and colleagues from Ophthalmologists Association Thun, Switzerland and Yale University School of Medicine, New Haven, USA defined PCI as the ration between untreated IOP and CCT3 in mm (ultrasound pachymetry).

PCI was then investigated in 220 normal controls, 53 subjects with normal-tension glaucoma (NTG), 76 with ocular hypertension (OHT) and 89 with primary open-angle glaucoma (POAG). The ability of PCI to discriminate between glaucoma and non-glaucoma was compared with that of three other formulae for correcting IOP for CCT. Receiver operating characteristic curves (ROC) were then built.

The mean PCI value in the control group was 92.0, 129.1 in the NTG group, 134.0 in the OHT group and 173.6 in the POAG group. PCI demonstrated a larger area under the ROC and significantly higher sensitivity at fixed 80% and 90% specificities than any of the other formulae. Optimum PCI cut-off value was 133.8.

The authors believe that PCI may reflect individual susceptibility to a given IOP level and, therefore, represents a glaucoma risk factor.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.